Effect of peroxisome proliferator-activated receptor α ligand fenofibrate on Kv channels in the insulin-secreting cell line HIT-T15

General Physiology and Biophysics

Volumn 25, Issue 4, 2006, Pages 455-460

  Shimomura, Kenju ^a,e   Ikeda, M ^b   Ariyama, Y ^a   Proks, P ^c   Shimomura, Y ^d   Mori, M ^a   Matsumoto, S ^b  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON DENTAL UNIVERSITY   (Japan)

^c INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

^d GUNMA PREFECTURAL COLLEGE OF HEALTH SCIENCES   (Japan)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Fenofibrate; Insulin secretion; Kv channel; Pancreatic cell; PPAR

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); FENOFIBRATE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POTASSIUM ION; VOLTAGE GATED POTASSIUM CHANNEL;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME INHIBITION; INSULIN RELEASE; NONHUMAN; POTASSIUM CURRENT; REDUCTION;

ANIMALS; CELL LINE; CRICETINAE; DOSE-RESPONSE RELATIONSHIP, DRUG; INSULIN-SECRETING CELLS; ION CHANNEL GATING; POTASSIUM CHANNELS; PPAR ALPHA; PROCETOFEN;

CRICETINAE;

EID: 33947263056     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ashcroft F. M., Rorsman P. (1989): Electrophysiology of the pancreatic β-cell. Prog. Biophys. Mol. Biol. 54, 87-143
2. + channels and insulin secretion: their role in health and disease. Diabetologia 42, 903-919
3. Atwater I., Ribalet B., Rojas E. (1979): Mouse pancreatic β-cells: tetraethylammonium blockage of the potassium permeability increase induced by depolarization. J. Physiol. (London) 288, 561-574
4. + channels in mouse pancreatic β cells. J. Physiol. (London) 423, 311-325
5. Braissant O., Foufelle F., Scotto C., Dauca M., Wahli W. (1996): Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR- α,-β and -γ in the adult rat. Endocrinology 137, 354-366
6. Caldwell J. (1989): The biochemical pharmacology of fenofibrate. Cardiology 76 (Suppl. 1), S33-44
7. Henquin J. C., Meissener H. P., Preissler M. (1979): 9-aminoacridine- and tetraethyl-ammonium-induced reduction of the potassium permeability in pancreatic β-cells. Effects on insulin release and electrical properties. Biochim. Biophys. Acta 587, 579-592
8. 2+ channels in pancreatic β-cell. Eur. J. Pharmacol. 427, 97-104
9. Lee C. H., Olson P., Evans R. M. (2003): Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors. Endocrinology 144, 2201-2207
10. + channels in pancreatic β cells: role, regulation and potential as therapeutic targets. Diabetologia 46, 1046-1062
11. + channel families regulate insulin secretion. Mol. Endocrinol. 15, 1423-1435
12. + channels in pancreatic β-cells enhances glucose-dependent insulin secretion. J. Biol. Chem. 277, 44938-44945
13. Misler S., Barnett D. W., Gillis K. D., Pressel D. M. (1992): Electrophysiology of stimulus-secretion coupling in human β-cells. Diabetes 41, 1221-1228
14. + channel overexpression in transgenic islets and β-cells associated with impaired glucose responsiveness. J. Biol. Chem. 269, 27787-27790
15. Proks P., Lippiat J. D. (2006): Membrane ion channels and diabetes. Curr. Pharm. Des. 12, 485-501
16. Rorsman P. (1997): The pancreatic β-cell as a fuel sensor: an electrophysiologist's viewpoint. Diabetologia 40, 487-495
17. + currents in pancreatic β cells are regulated by intracellular ATP. Pflügers. Arch. 405, 305-309
18. 2+ action potentials. Biophys. J. 66, 141-148
19. ATP channel and induce insulin secretion. J. Pharmacol. Exp. Ther. 310, 1273-1280
20. Tamarina N. A., Kuznetsov A., Fridlyand L. E., Philipson L. H. (2005): Delayed-rectifier Kν2.1) regulation of pancreatic β-cell clcium responces to glucose: inhibitor specificity and modeling. Am. J. Physiol., Endocrinol. Metab. 289, E578-585